Olaparib
Olaparib
Definition
A small molecule inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential chemosensitizing, radiosensitizing, and antineoplastic activities. Olaparib selectively binds to and inhibits PARP, inhibiting PARP-mediated repair of single strand DNA breaks; PARP inhibition may enhance the cytotoxicity of DNA-damaging agents and may reverse tumor cell chemoresistance and radioresistance. PARP catalyzes post-translational ADP-ribosylation of nuclear proteins and can be activated by single-stranded DNA breaks.
Also known as AZD 2281, AZD-2281, AZD2281, KU 0059436, KU-0059436, KU0059436, Lynparza, Olanib, OLAPARIB, Olaparix, PARP Inhibitor AZD2281 — per NCIT
Also identified as
- ATC L01XK01 per RXNORM
- NCIT NCIT:C71721 per NCIT
- SCTID 432162002 per RXNORM
- SCTID 432885003 per RXNORM
- UNII WOH1JD9AR8 per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Ovarian cancer | may treat | MEDRT · Public domain (U.S. Government work) |